Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 255

    1.

    Effects of neuropeptides and leptin on nutrient partitioning: dysregulations in obesity.

    Jeanrenaud B, Rohner-Jeanrenaud F.

    Annu Rev Med. 2001;52:339-51. Review.PMID: 11160783 [PubMed - indexed for MEDLINE]Related articles

    2.

    CNS-periphery relationships and body weight homeostasis: influence of the glucocorticoid status.

    Jeanrenaud B, Rohner-Jeanrenaud F.

    Int J Obes Relat Metab Disord. 2000 Jun;24 Suppl 2:S74-6. Review.PMID: 10997614 [PubMed - indexed for MEDLINE]Related articles

    3.

    Effects of intravenously infused leptin on insulin sensitivity and on the expression of uncoupling proteins in brown adipose tissue.

    Rouru J, Cusin I, Zakrzewska KE, Jeanrenaud B, Rohner-Jeanrenaud F.

    Endocrinology. 1999 Aug;140(8):3688-92.PMID: 10433228 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Selective dependence of intracerebroventricular neuropeptide Y-elicited effects on central glucocorticoids.

    Zakrzewska KE, Sainsbury A, Cusin I, Rouru J, Jeanrenaud B, Rohner-Jeanrenaud F.

    Endocrinology. 1999 Jul;140(7):3183-7.PMID: 10385413 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Induction of obesity and hyperleptinemia by central glucocorticoid infusion in the rat.

    Zakrzewska KE, Cusin I, Stricker-Krongrad A, Boss O, Ricquier D, Jeanrenaud B, Rohner-Jeanrenaud F.

    Diabetes. 1999 Feb;48(2):365-70.PMID: 10334315 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    [From Claude Bernard to the regulatory system between the hypothalamus and the periphery: implications for homeostasis of body weight and obesity]

    Jeanrenaud B, Cusin I, Rohner-Jeanrenaud F.

    C R Seances Soc Biol Fil. 1998;192(5):829-41. Review. French. PMID: 9871796 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effects of intravenous neuropeptide Y on insulin secretion and insulin sensitivity in skeletal muscle in normal rats.

    Vettor R, Pagano C, Granzotto M, Englaro P, Angeli P, Blum WF, Federspil G, Rohner-Jeanrenaud F, Jeanrenaud B.

    Diabetologia. 1998 Nov;41(11):1361-7.PMID: 9833945 [PubMed - indexed for MEDLINE]Related articles

    8.

    Chronic central leptin infusion enhances insulin-stimulated glucose metabolism and favors the expression of uncoupling proteins.

    Cusin I, Zakrzewska KE, Boss O, Muzzin P, Giacobino JP, Ricquier D, Jeanrenaud B, Rohner-Jeanrenaud F.

    Diabetes. 1998 Jul;47(7):1014-9.PMID: 9648822 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinaemia.

    Sainsbury A, Rohner-Jeanrenaud F, Cusin I, Zakrzewska KE, Halban PA, Gaillard RC, Jeanrenaud B.

    Diabetologia. 1997 Nov;40(11):1269-77.PMID: 9389418 [PubMed - indexed for MEDLINE]Related articles

    10.

    Lactate infusion in anesthetized rats produces insulin resistance in heart and skeletal muscles.

    Vettor R, Lombardi AM, Fabris R, Pagano C, Cusin I, Rohner-Jeanrenaud F, Federspil G, Jeanrenaud B.

    Metabolism. 1997 Jun;46(6):684-90.PMID: 9186306 [PubMed - indexed for MEDLINE]Related articles

    11.

    Endogenous glucose production, gluconeogenesis and liver glycogen concentration in obese non-diabetic patients.

    Müller C, Assimacopoulos-Jeannet F, Mosimann F, Schneiter P, Riou JP, Pachiaudi C, Felber JP, Jéquier E, Jeanrenaud B, Tappy L.

    Diabetologia. 1997 Apr;40(4):463-8.PMID: 9112024 [PubMed - indexed for MEDLINE]Related articles

    12.

    Glucocorticoids as counterregulatory hormones of leptin: toward an understanding of leptin resistance.

    Zakrzewska KE, Cusin I, Sainsbury A, Rohner-Jeanrenaud F, Jeanrenaud B.

    Diabetes. 1997 Apr;46(4):717-9.PMID: 9075817 [PubMed - indexed for MEDLINE]Related articles

    13.

    Adrenalectomy prevents the obesity syndrome produced by chronic central neuropeptide Y infusion in normal rats.

    Sainsbury A, Cusin I, Rohner-Jeanrenaud F, Jeanrenaud B.

    Diabetes. 1997 Feb;46(2):209-14.PMID: 9000696 [PubMed - indexed for MEDLINE]Related articles

    14.

    Central nervous system and body weight regulation.

    Rohner-Jeanrenaud E, Jeanrenaud B.

    Ann Endocrinol (Paris). 1997;58(2):137-42. Review.PMID: 9239233 [PubMed - indexed for MEDLINE]Related articles

    15.

    The discovery of leptin and its impact in the understanding of obesity.

    Rohner-Jeanrenaud F, Jeanrenaud B.

    Eur J Endocrinol. 1996 Dec;135(6):649-50. No abstract available. PMID: 9025704 [PubMed - indexed for MEDLINE]Related articles

    16.

    The loop system between neuropeptide Y and leptin in normal and obese rodents.

    Rohner-Jeanrenaud F, Cusin I, Sainsbury A, Zakrzewska KE, Jeanrenaud B.

    Horm Metab Res. 1996 Dec;28(12):642-8. Review.PMID: 9013734 [PubMed - indexed for MEDLINE]Related articles

    17.

    The weight-reducing effect of an intracerebroventricular bolus injection of leptin in genetically obese fa/fa rats. Reduced sensitivity compared with lean animals.

    Cusin I, Rohner-Jeanrenaud F, Stricker-Krongrad A, Jeanrenaud B.

    Diabetes. 1996 Oct;45(10):1446-50.PMID: 8826985 [PubMed - indexed for MEDLINE]Related articles

    18.

    Acute intracerebroventricular administration of neuropeptide Y stimulates corticosterone output and feeding but not insulin output in normal rats.

    Sainsbury A, Rohner-Jeanrenaud F, Grouzmann E, Jeanrenaud B.

    Neuroendocrinology. 1996 Apr;63(4):318-26.PMID: 8739887 [PubMed - indexed for MEDLINE]Related articles

    19.

    Intracerebroventricular administration of neuropeptide Y to normal rats increases obese gene expression in white adipose tissue.

    Sainsbury A, Cusin I, Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B.

    Diabetologia. 1996 Mar;39(3):353-6.PMID: 8721783 [PubMed - indexed for MEDLINE]Related articles

    20.

    Obesity, leptin, and the brain.

    Rohner-Jeanrenaud F, Jeanrenaud B.

    N Engl J Med. 1996 Feb 1;334(5):324-5. No abstract available. PMID: 8532032 [PubMed - indexed for MEDLINE]Related articles

    21.

    Endothelial function of the mesenteric arteriole and mechanical behaviour of the carotid artery in rats with insulin resistance and hypercholesterolaemia.

    Zanchi A, Delacrétaz E, Taleb V, Gaillard R, Jeanrenaud B, Brunner HR, Waeber B.

    J Hypertens. 1995 Dec;13(12 Pt 1):1463-70.PMID: 8866909 [PubMed - indexed for MEDLINE]Related articles

    22.

    The ob gene and insulin. A relationship leading to clues to the understanding of obesity.

    Cusin I, Sainsbury A, Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B.

    Diabetes. 1995 Dec;44(12):1467-70.PMID: 7589856 [PubMed - indexed for MEDLINE]Related articles

    23.

    Insulin, corticosterone and the autonomic nervous system in animal obesities: a viewpoint.

    Jeanrenaud B.

    Diabetologia. 1995 Aug;38(8):998-1002. Review. No abstract available. PMID: 7589889 [PubMed - indexed for MEDLINE]Related articles

    24.

    Four-day hyperinsulinemia in euglycemic conditions alters local cerebral glucose utilization in specific brain nuclei of freely moving rats.

    Doyle P, Cusin I, Rohner-Jeanrenaud F, Jeanrenaud B.

    Brain Res. 1995 Jun 26;684(1):47-55.PMID: 7583203 [PubMed - indexed for MEDLINE]Related articles

    25.

    Effect of sustained physiological hyperinsulinaemia on hypothalamic neuropeptide Y and NPY mRNA levels in the rat.

    Cusin I, Dryden S, Wang Q, Rohner-Jeanrenaud F, Jeanrenaud B, Williams G.

    J Neuroendocrinol. 1995 Mar;7(3):193-7.PMID: 7606245 [PubMed - indexed for MEDLINE]Related articles

    26.

    In vivo effects of hyperinsulinemia on lipogenic enzymes and glucose transporter expression in rat liver and adipose tissues.

    Assimacopoulos-Jeannet F, Brichard S, Rencurel F, Cusin I, Jeanrenaud B.

    Metabolism. 1995 Feb;44(2):228-33.PMID: 7869920 [PubMed - indexed for MEDLINE]Related articles

    27.

    [Role of the central nervous system in the development of obesity]

    Jeanrenaud B, Cusin I, Doyle P, Rohner-Jeanrenaud F.

    Journ Annu Diabetol Hotel Dieu. 1995:141-6. Review. French. No abstract available. PMID: 7602876 [PubMed - indexed for MEDLINE]Related articles

    28.

    Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats.

    Vettor R, Zarjevski N, Cusin I, Rohner-Jeanrenaud F, Jeanrenaud B.

    Diabetologia. 1994 Dec;37(12):1202-8.PMID: 7895949 [PubMed - indexed for MEDLINE]Related articles

    29.

    Insulin resistance and hypertension: studies in transgenic hypertensive TGR(mREN-2)27 rats.

    Vettor R, Cusin I, Ganten D, Rohner-Jeanrenaud F, Ferrannini E, Jeanrenaud B.

    Am J Physiol. 1994 Dec;267(6 Pt 2):R1503-9.PMID: 7810759 [PubMed - indexed for MEDLINE]Related articles

    30.

    Central nervous system and peripheral abnormalities: clues to the understanding of obesity and NIDDM.

    Jeanrenaud B.

    Diabetologia. 1994 Sep;37 Suppl 2:S170-8. Review.PMID: 7821733 [PubMed - indexed for MEDLINE]Related articles

    31.

    Alterations of local cerebral glucose utilization in lean and obese fa/fa rats after acute adrenalectomy.

    Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B.

    Brain Res. 1994 Aug 29;655(1-2):115-20.PMID: 7812762 [PubMed - indexed for MEDLINE]Related articles

    32.

    Intracerebroventricular administration of neuropeptide Y to normal rats has divergent effects on glucose utilization by adipose tissue and skeletal muscle.

    Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, Jeanrenaud B.

    Diabetes. 1994 Jun;43(6):764-9.PMID: 8194661 [PubMed - indexed for MEDLINE]Related articles

    33.

    Effects of corticosterone administration on local cerebral glucose utilization of rats.

    Doyle P, Guillaume-Gentil C, Rohner-Jeanrenaud F, Jeanrenaud B.

    Brain Res. 1994 May 9;645(1-2):225-30.PMID: 8062085 [PubMed - indexed for MEDLINE]Related articles

    34.

    Modifications of glucose and lipid metabolism in cold-acclimated lean and genetically obese rats.

    Bobbioni-Harsch E, Assimacopoulos-Jeannet F, Jeanrenaud B.

    J Appl Physiol. 1994 Mar;76(3):1106-12.PMID: 8005851 [PubMed - indexed for MEDLINE]Related articles

    35.

    In vivo regulation of adipose tissue lipoprotein lipase in normal rats made hyperinsulinemic and in hyperinsulinemic genetically-obese (fa/fa) rats.

    Terrettaz J, Cusin I, Etienne J, Jeanrenaud B.

    Int J Obes Relat Metab Disord. 1994 Jan;18(1):9-15.PMID: 8130818 [PubMed - indexed for MEDLINE]Related articles

    36.

    Lifespan of subcutaneous glucose sensors and their performances during dynamic glycaemia changes in rats.

    Bobbioni-Harsch E, Rohner-Jeanrenaud F, Koudelka M, de Rooij N, Jeanrenaud B.

    J Biomed Eng. 1993 Nov;15(6):457-63.PMID: 8277748 [PubMed - indexed for MEDLINE]Related articles

    37.

    Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity.

    Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, Jeanrenaud B.

    Endocrinology. 1993 Oct;133(4):1753-8.PMID: 8404618 [PubMed - indexed for MEDLINE]Related articles

    38.

    Involvement of non-esterified fatty acid oxidation in glucocorticoid-induced peripheral insulin resistance in vivo in rats.

    Guillaume-Gentil C, Assimacopoulos-Jeannet F, Jeanrenaud B.

    Diabetologia. 1993 Oct;36(10):899-906.PMID: 8243867 [PubMed - indexed for MEDLINE]Related articles

    39.

    Hypothalamic neuropeptide Y messenger ribonucleic acid levels in pre-obese and genetically obese (fa/fa) rats; potential regulation thereof by corticotropin-releasing factor.

    Bchini-Hooft van Huijsduijnen OB, Rohner-Jeanrenaud F, Jeanrenaud B.

    J Neuroendocrinol. 1993 Aug;5(4):381-6.PMID: 8401561 [PubMed - indexed for MEDLINE]Related articles

    40.

    Insulin resistance syndrome: defective GABA neuromodulation as a possible hereditary pathogenetic factor (the 'GABA hypothesis').

    Blasi C, Jeanrenaud B.

    Med Hypotheses. 1993 Apr;40(4):197-206.PMID: 8391625 [PubMed - indexed for MEDLINE]Related articles

    41.

    Local cerebral glucose utilization in brains of lean and genetically obese (fa/fa) rats.

    Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B.

    Am J Physiol. 1993 Jan;264(1 Pt 1):E29-36.PMID: 8430785 [PubMed - indexed for MEDLINE]Related articles

    42.

    Hyperinsulinemia and its impact on obesity and insulin resistance.

    Cusin I, Rohner-Jeanrenaud F, Terrettaz J, Jeanrenaud B.

    Int J Obes Relat Metab Disord. 1992 Dec;16 Suppl 4:S1-11.PMID: 1338381 [PubMed - indexed for MEDLINE]Related articles

    43.

    The importance of the brain in the aetiology of obesity and type 2 diabetes.

    Jeanrenaud B, Rohner-Jeanrenaud F, Cusin I, Zarjevski N, Assimacopoulos-Jeannet F, Guillaume-Gentil C, van Huijsduijnen OB, Doyle P.

    Int J Obes Relat Metab Disord. 1992 Dec;16 Suppl 2:S9-12. No abstract available. PMID: 1335994 [PubMed - indexed for MEDLINE]Related articles

    44.

    Glucose regulates its transport in L8 myocytes by modulating cellular trafficking of the transporter GLUT-1.

    Greco-Perotto R, Wertheimer E, Jeanrenaud B, Cerasi E, Sasson S.

    Biochem J. 1992 Aug 15;286 ( Pt 1):157-63.PMID: 1520263 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Vanadate treatment markedly increases glucose utilization in muscle of insulin-resistant fa/fa rats without modifying glucose transporter expression.

    Brichard SM, Assimacopoulos-Jeannet F, Jeanrenaud B.

    Endocrinology. 1992 Jul;131(1):311-7.PMID: 1612011 [PubMed - indexed for MEDLINE]Related articles

    46.

    Effect of a beta-adrenergic agonist on glucose transport and insulin-responsive glucose transporters (GLUT4) in brown adipose tissue of control and obese fa/fa rats.

    Assimacopoulos-Jeannet F, Greco-Perotto R, Terrettaz J, Meier MK, Jeanrenaud B.

    Pflugers Arch. 1992 May;421(1):52-8.PMID: 1352872 [PubMed - indexed for MEDLINE]Related articles

    47.

    Beneficial effect of intravenous bolus of corticotropin-releasing factor on glucose intolerance of genetically obese (fa/fa) rats.

    Rohner-Jeanrenaud F, Jeanrenaud B.

    Diabetes. 1992 Apr;41(4):493-8.PMID: 1607074 [PubMed - indexed for MEDLINE]Related articles

    48.

    The contribution of hyperglycaemia and hypoinsulinaemia to the insulin resistance of streptozotocin-diabetic rats.

    Lisato G, Cusin I, Tiengo A, Del Prato S, Jeanrenaud B.

    Diabetologia. 1992 Apr;35(4):310-5.PMID: 1516758 [PubMed - indexed for MEDLINE]Related articles

    49.

    Acute intravenous corticotropin-releasing factor administration: effects on insulin secretion in lean and genetically obese fa/fa rats.

    Rohner-Jeanrenaud F, Jeanrenaud B.

    Endocrinology. 1992 Apr;130(4):1903-8.PMID: 1312430 [PubMed - indexed for MEDLINE]Related articles

    50.

    Muscle insulin resistance may not be a primary etiological factor in the genetically obese fa/fa rat.

    Zarjevski N, Doyle P, Jeanrenaud B.

    Endocrinology. 1992 Mar;130(3):1564-70.PMID: 1537306 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...